Patient Enrollment in Oncology Clinical Trials - Challenges & Best Solutions
Webinar
Oncology clinical trials have brought huge advances in arena of cancer prevention, treatment and diagnosis. However, oncology clinical trials warrant a significant investment in terms of cost, resources and time. The most of the cancer clinical trials are long & complex and need a varied approach than other therapeutic areas to understand and overcome the various challenges throughout the study conduct.
Patient enrollment has always been a challenge in clinical trials, in general and it is more so in oncology clinical trials. Oncology clinical trials take longer time than other therapeutic areas primarily due to delays in patient enrollment. In US, the adult participation in cancer clinical trials remains around 3% with even lower participation rates among ethnic, racial minorities and elderly people. Sponsors/CROs and sites increasingly struggle to reach enrollment targets due to a variety of reasons including nature of disease itself. However, understanding, analyzing these challenges & barriers in patient enrollment in oncology trials and addressing them with thoughtful, strategic, result-oriented plans & procedures is the key to success.
(Courtesy of http://www.makrocare.com/)
Wed, Nov 28, 2012 - Wed, Nov 28, 2012
2:00pm to 3:00pm (GMT-05:00) Eastern Time (US & Canada)
Online: http://www.makrocare.com/index.php/en/webinar-patient-enrollment-in-oncology-clinical-trials
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.